Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin Consolidation in Follicular Lymphoma (FIT Trial)
NCT00185393Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2001
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of ibritumomab tiuxetan in follicular lymphoma (FL), sponsored by Bayer. Started Aug 2001; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00185393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185393.